Knowing how to read a peptide COA (certificate of analysis) is the single most useful skill a research buyer can develop when evaluating supplier quality. A COA is the batch-specific analytical record that documents what a peptide preparation actually contains — its chromatographic purity, its confirmed molecular identity, its net peptide content, and the residual impurities left behind from synthesis. Rather than taking a "≥99% purity" marketing claim at face value, a properly issued COA lets you verify that number against the underlying instrument data. This guide walks through every section of a typical research-peptide COA and explains what each value means, what "good" looks like, and which red flags should make you pause before accepting a batch into an experimental workflow.
Research Use Only. All peptides referenced here are supplied strictly for laboratory, in-vitro, and preclinical research use only. They are not for human or veterinary use, are not dietary supplements or drugs, and have not been evaluated by the FDA. Nothing here is intended to diagnose, treat, cure, or prevent any disease, and no human handling or dosing is described or implied.
What a COA is (and is not)
A certificate of analysis is a document tied to a specific manufactured lot. That batch specificity is what distinguishes a real COA from a generic spec sheet. A spec sheet says "this product should be ≥99% pure." A COA says "lot #NL-240118 was tested on this date, by this method, and measured 99.2%." If a supplier shows you the same PDF for every batch, or a document with no lot number, no test date, and no signature, you are looking at a spec sheet dressed up as a COA — not a verification record. For the deeper context on why independent verification matters, see Third-Party Peptide Testing: Why It Matters and the parent overview, Peptide COA, Purity & Third-Party Testing.
Section 1: Header and batch identifiers
Start at the top. A trustworthy COA header carries every identifier you would need to trace the batch:
- Product name and sequence — the peptide name plus, ideally, the one-letter or three-letter amino acid sequence.
- CAS number — a unique registry identifier for the compound where one exists.
- Lot / batch number — must be present and should match the vial label.
- Molecular formula and molecular weight — the theoretical values the identity tests are checked against.
- Manufacture and test dates, and often a retest or expiry date.
- Storage conditions — commonly lyophilized at −20 °C, protected from light and moisture.
Cross-check the molecular weight in the header against the mass observed in the mass-spec section later. Those two numbers must agree.
Section 2: HPLC purity — the headline number
The purity percentage almost always comes from reverse-phase high-performance liquid chromatography (RP-HPLC). This is the "≥99%" figure most buyers focus on, and it deserves scrutiny beyond the number itself. On the chromatogram, purity is calculated as the area of the main peak divided by the total area of all peaks, expressed as a percentage. A clean research-grade peptide shows one dominant, sharp, symmetrical peak with minimal baseline noise and only small satellite peaks.
When reading the HPLC section, look at:
- The reported purity % — for research peptides, ≥98–99% is the common standard.
- The method line — column type (e.g., C18), mobile phase gradient (typically water/acetonitrile with 0.1% TFA), flow rate, and detection wavelength (often 214 or 220 nm, where the peptide bond absorbs).
- The chromatogram image itself — a number with no trace is easy to fabricate. A visible chromatogram with a labeled retention time is far more credible.
Detection wavelength matters: 214 nm detects the peptide backbone broadly, while 280 nm only sees aromatic residues (Trp, Tyr, Phe) and can flatter a sample. Our full breakdown of the method lives in HPLC Peptide Purity Testing Explained.
Section 3: Mass spectrometry — identity confirmation
Purity tells you how much of the sample is one compound; it does not tell you which compound. That is the job of mass spectrometry. The MS section reports the observed mass and compares it to the theoretical (calculated) mass from the header. For ESI-MS you will often see multiply-charged ions such as [M+H]⁺, [M+2H]²⁺, or [M+3H]³⁺; MALDI-TOF typically reports a singly-charged [M+H]⁺.
The observed and theoretical masses should match within the instrument's expected tolerance. A mismatch of one or two mass units can indicate a deletion sequence, an incomplete deprotection, or an unintended modification. If the COA lists a purity figure but no mass-spec confirmation, you cannot be certain the main HPLC peak is even the intended peptide. See Mass Spec Peptide Identity Verification for how to interpret the charge envelope.
Section 4: Net peptide content and counter-ion
This is the most overlooked line on a COA. A lyophilized "peptide" powder is rarely 100% peptide by mass. It also contains bound water, residual counter-ions (usually acetate or trifluoroacetate from purification), and any residual salts. Net peptide content — determined by amino acid analysis or nitrogen content — tells you the actual fraction of true peptide, and it is often 70–90% of the powder mass even when HPLC purity is 99%.
Do not confuse the two: purity describes the peptide fraction relative to other peptide-like impurities; content describes peptide relative to the whole powder. Both are legitimate and describe different things. For labs preparing gravimetric research solutions, net content is what governs the true concentration of the active species in a reconstituted preparation.
Section 5: Water content, residual solvents, and appearance
Rounding out the analytical panel:
- Water content — often by Karl Fischer titration; high moisture accelerates degradation of a lyophilized research preparation.
- Residual solvents — trace acetonitrile, TFA, or acetic acid left from synthesis and purification.
- Appearance — typically "white to off-white lyophilized powder."
- Counter-ion type — acetate is generally preferred over TFA for many research applications because TFA can interfere with certain cell-based assays.
Section 6: Provenance — who signed it
Finally, check the footer. A credible COA names the testing laboratory, carries a signature or authorized approver, and — critically — indicates whether testing was performed in-house or by an independent third-party lab. Third-party results carry more weight because the tester has no commercial stake in the outcome. Batch-matched third-party COAs are the gold standard against peptide purity standards for research use.
A quick reference table
| COA Section | Method | What good looks like |
|---|---|---|
| Purity | RP-HPLC | ≥98–99%, single sharp peak, chromatogram shown |
| Identity | ESI-MS / MALDI-TOF | Observed mass matches theoretical within tolerance |
| Net peptide content | AAA / nitrogen | Reported (often 70–90%), not omitted |
| Water content | Karl Fischer | Low, single-digit % |
| Counter-ion | Stated | Acetate or TFA identified |
| Provenance | — | Lot #, date, signature, third-party lab |
Putting it into practice
Once you can read each section, verifying a batch becomes routine. Confirm the lot number matches the vial, check that HPLC purity meets your threshold with a visible chromatogram, confirm the mass-spec identity, and read the net content before calculating any research solution concentration. Every batch of BPC-157 (10mg) and TB-500 (10mg) we ship is accompanied by a batch-matched, third-party COA covering these sections. For a worked example on one compound, see BPC-157 Purity & Third-Party COA Testing.